The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
Open accessAbstract
Background: Cancer cachexia is a syndrome of weight loss (including muscle and fat), anorexia, and decreased physical function. It has been suggested that the optimal treatment for cachexia should be a multimodal intervention. The primary aim of this study was to examine the feasibility and safety of a multimodal intervention (n‐3 polyunsaturated fatty acid nutritional supplements, exercise, and anti‐inflammatory medication: celecoxib) for cancer cachexia in patients with incurable lung or pancreatic cancer, undergoing chemotherapy. Methods: Patients receiving two cycles of standard chemotherapy were randomized to either the multimodal cachexia intervention or standard care. Primary outcome measures were feasibility assessed by recruitment, attrition, and compliance with intervention (>50% of components in >50% of patients). Key secondary outcomes were change in weight, muscle mass, physical activity, safety, and survival. Results: Three hundred and ninety‐nine were screened resulting in 46 patients recruited (11.5%). Twenty five patients were randomized to the treatment and 21 as controls. Forty‐one completed the study (attrition rate 11%). Compliance to the individual components of the intervention was 76% for celecoxib, 60% for exercise, and 48% for nutritional supplements. As expected from the sample size, there was no statistically significant effect on physical activity or muscle mass. There were no intervention‐related Serious Adverse Events and survival was similar between the groups. Conclusions: A multimodal cachexia intervention is feasible and safe in patients with incurable lung or pancreatic cancer; however, compliance to nutritional supplements was suboptimal. A phase III study is now underway to assess fully the effect of the intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Self-citationSpruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938 · cited 1×
“chronic obstructive pulmonary disease (COPD)] where patient-centred outcomes such as physical activity level are used.(29)”
Development of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032 · cited 1×
“scale assessment of nutritional intake (AveS)](16); and fatigue [assessed using the Fatigue Severity Scale (FSS)].(17)”
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205
Self-citationSymptom Prevalence in Patients with Incurable Cancer: A Systematic Review
Teunissen, S. C. C. M., Wesker, W., Kruitwagen, C., de Haes, H. C. J. M., Voest, E. E., & de Graeff, A. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.10.015 · Cited by 990
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Prigerson, H. G., Bao, Y., Shah, M. A., Paulk, M. E., LeBlanc, T. W., Schneider, B. J., Garrido, M. M., Reid, M. C., Berlin, D. A., Adelson, K. B., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2378 · Cited by 645
Fearon, K. C. H. (2003) · Gut · doi:10.1136/gut.52.10.1479 · Cited by 603
Self-citationMoses, A. W. G., Slater, C., Preston, T., Barber, M. D., & Fearon, K. C. H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601620 · Cited by 452
Self-citationCancer cachexia: Developing multimodal therapy for a multidimensional problem
Fearon, K. C. H. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.033 · Cited by 444
Self-citationComputed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
Kazemi-Bajestani, S. M. R., Mazurak, V. C., & Baracos, V. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.09.001 · Cited by 313
Renal complications of nonsteroidal anti-inflammatory drugs
Schlondorff, D. (1993) · Kidney International · doi:10.1038/ki.1993.293 · Cited by 279
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
Awad, S., Tan, B. H., Cui, H., Bhalla, A., Fearon, K. C. H., Parsons, S. L., Catton, J. A., & Lobo, D. N. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.08.008 · Cited by 269
Self-citationHui, D., Glitza, I., Chisholm, G., Yennu, S., & Bruera, E. (2013) · Cancer · doi:10.1002/cncr.27854 · Cited by 250
Lundholm, K., Daneryd, P., Bosaeus, I., Körner, U., & Lindholm, E. (2004) · Cancer · doi:10.1002/cncr.20160 · Cited by 235
Mantovani, G., Macciò, A., Madeddu, C., Serpe, R., Massa, E., Dessì, M., Panzone, F., & Contu, P. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0153 · Cited by 231
Laird, B. J., Kaasa, S., McMillan, D. C., Fallon, M. T., Hjermstad, M. J., Fayers, P., & Klepstad, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1066 · Cited by 211
Self-citationStene, G. B., Helbostad, J. L., Balstad, T. R., Riphagen, I. I., Kaasa, S., & Oldervoll, L. M. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.001 · Cited by 210
Self-citationvon Haehling, S., Morley, J. E., Coats, A. J. S., & Anker, S. D. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12089 · Cited by 199
van der Meij, B. S., Langius, J. A. E., Smit, E. F., Spreeuwenberg, M. D., von Blomberg, B. M. E., Heijboer, A. C., Paul, M. A., & van Leeuwen, P. A. M. (2010) · The Journal of Nutrition · doi:10.3945/jn.110.121202 · Cited by 198
Popuri, K., Cobzaş, D., Esfandiari, N., Baracos, V. E., & Jägersand, M. (2015) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2015.2479252 · Cited by 151
Macciò, A., Madeddu, C., Gramignano, G., Mulas, C., Floris, C., Sanna, E., Cau, M. C., Panzone, F., & Mantovani, G. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.12.435 · Cited by 146
Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review
Solheim, T. S., Fearon, K. C. H., Blum, D., & Kaasa, S. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.724536 · Cited by 122
Self-citationClinical Outcomes and Contributors to Weight Loss in a Cancer Cachexia Clinic
Fabbro, E. D., Hui, D. S. C., Dalal, S., Dev, R., Nooruddin, Z. I., & Bruera, E. D. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2011.0098 · Cited by 121
Vigano, A. L., di Tomasso, J., Kilgour, R. D., Trutschnigg, B., Lucar, E., Morais, J. A., & Borod, M. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.09.027 · Cited by 111
Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia
Murphy, R. A., Yeung, E., Mazurak, V. C., & Mourtzakis, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.391 · Cited by 108
Balstad, T. R., Solheim, T. S., Strasser, F., Kaasa, S., & Bye, A. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.02.005 · Cited by 104
Self-citationThibault, R., Goujon, N., Le Gallic, E., Clairand, R., Sébille, V., Vibert, J., Schneider, S. M., & Darmaun, D. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.01.003 · Cited by 99
Exercise for cancer cachexia in adults
Grande, A. J., Silva, V., Riera, R., Medeiros, A., Vitoriano, S., Peccin, M. S., & Maddocks, M. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010804.pub2 · Cited by 96
LeBlanc, T. W., Nipp, R. D., Rushing, C. N., Samsa, G., Locke, S. C., Kamal, A. H., Cella, D. F., & Abernethy, A. P. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.09.008 · Cited by 76
Fallon, M., Hoskin, P., Colvin, L., Fleetwood-Walker, S. M., Adamson, D. J. A., Byrne, A., Murray, G. D., & Laird, B. J. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.8221 · Cited by 68
Self-citationSkipworth, R. J. E., Stene, G. B., Dahele, M. R., Hendry, P. O., Small, A. C., Blum, D., Kaasa, S., Trottenberg, P., Radbruch, L., Strasser, F., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.05.010 · Cited by 56
Self-citationRhondali, W., Chisholm, G. B., Daneshmand, M., Allo, J. A., Kang, D.-H., Filbet, M., Hui, D., Fingeret, M. C., & Bruera, E. D. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.06.013 · Cited by 50
Evidence base for multimodal therapy in cachexia
Solheim, T. S., & Laird, B. J. A. (2012) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328359b668 · Cited by 50
Self-citationFactors affecting recruitment to an observational multicentre palliative care study
Stone, P. C., Gwilliam, B., Keeley, V. L., Todd, C. J., Kelly, L., & Barclay, S. I. G. (2013) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2012-000396 · Cited by 40
Müller, M. J., Baracos, V. E., Bosy‐Westphal, A., Dulloo, A. G., Eckel, J., Fearon, K. C. H., Hall, K. D., Pietrobelli, A., Sørensen, T. I. A., Speakman, J. R., et al. (2014) · Obesity Reviews · doi:10.1111/obr.12187 · Cited by 25
Self-citationParmar, M. P., Swanson, T. M., & Jagoe, R. T. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1762-2 · Cited by 25
Exercise for cancer cachexia in adults
Grande, A. J., Silva, V., Maddocks, M. M., Riera, R., Medeiros, A., Vitoriano, S., & Peccin, M. S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010804 · Cited by 17
Cited by
Management of Cancer Cachexia: ASCO Guideline
Roeland, E. J., Bohlke, K., Baracos, V. E., Bruera, E., del Fabbro, E., Dixon, S., Fallon, M., Herrstedt, J., Lau, H., Platek, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00611 · Cited by 644
Self-citationCancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
Arends, J., Strasser, F., Gonella, S., Solheim, T. S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M. A. E., Baldwin, C., Chasen, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100092 · Cited by 586
Self-citationThe Exercise and Sports Science Australia position statement: Exercise medicine in cancer management
Hayes, S. C., Newton, R. U., Spence, R. R., & Galvão, D. A. (2019) · Journal of Science and Medicine in Sport · doi:10.1016/j.jsams.2019.05.003 · Cited by 506
Nutrition interventions to treat low muscle mass in cancer
Prado, C. M., Purcell, S. A., & Laviano, A. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12525 · Cited by 392
European Society for Medical Oncology (ESMO) position paper on supportive and palliative care
Jordan, K., Aapro, M., Kaasa, S., Ripamonti, C. I., Scotté, F., Strasser, F., Young, A., Bruera, E., Herrstedt, J., Keefe, D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx757 · Cited by 374
Self-citation
Metadata
- Authors
- Solheim, T. S., Laird, B. J. A., Balstad, T. R., Stene, G. B., Bye, A., Johns, N., Pettersen, C. H., Fallon, M., Fayers, P., Fearon, K., & Kaasa, S.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2017-06-14
- Volume
- 8
- Issue
- 5
- Pages
- 778-788
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W2626721982
- Cited by
- 311
- References
- 38
- FWCI
- 18.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.